Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)

PHASE4CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Eye DiseasesGlaucoma, Open-AngleGlaucoma
Interventions
DEVICE

iStent

iStent

DRUG

latanoprost/timolol

Combination latanoprost/timolol

Trial Locations (16)

1090

Allgemeines Krankenhaus Wien, Vienna

10128

Universita' di Torino/Dipartimento di Fisiopatologia Clinica-Clinica Oculistica, Torino

28040

Hospital Clinico San Carlos, Madrid

33100

Azienda Ospedaliera S. Maria della Misericordia, Udine

43100

Universita'degli Studi di Parma, Parma

44892

Knapschaftskrankenhaus Bochum Langendreer, Bochum

69437

CHU de Lyon Hopital Edouard Herriot, Lyon

75012

CHNO des Quinze-Vingts, Paris

99089

Helios Cliniic, Erfurt

Unknown

SV Malayan Ophthalmological Center, Yerevan

Universitatsklinkum Erlangen, Erlangen

Hospital Universitario Miguel Servet, Zaragoza

Hinchingbrooke Hospital Moorfields, Bedford

546 36

AHEPA Hospital, Thessaloniki

00-909

Military Health Service Institute, Warsaw

03186

Hospital Torrevieja Salud, UTE, Alicante

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY